Correction to: Dual Antiplatelet Therapy Duration in Medically Managed Acute Coronary Syndrome Patients: Sub-Analysis of the OPT-CAD Study

Correction to: Adv Ther https://doi.org/10.1007/s12325-020-01376-0

In the original article, the incorrect funding statement has been published. The correct funding statement is "This study is supported by the national key R&D project (contract no. 2016YFC1301303, 2016YFC1301300) and an investigator-initiated grant by AstraZenca Co. Ltd. No funding was received for the journals rapid service fee".

Author information

Affiliations

Authors

Corresponding author

Correspondence to Yaling Han.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ma, S., Jiang, Z., Qiu, M. et al. Correction to: Dual Antiplatelet Therapy Duration in Medically Managed Acute Coronary Syndrome Patients: Sub-Analysis of the OPT-CAD Study. Adv Ther 37, 3162 (2020). https://doi.org/10.1007/s12325-020-01401-2

Download citation